Oligodendrocyte Lineage Gene Function in the CNS
少突胶质细胞谱系基因在中枢神经系统中的功能
基本信息
- 批准号:8204933
- 负责人:
- 金额:$ 43.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-08-01 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAntibodiesAvian SarcomaAvian Sarcoma VirusesBiochemicalBiologicalCell CycleCell LineCell NucleusCellsChromatinComplexDNA SequenceDemyelinating DiseasesDevelopmental BiologyEmbryoGene TargetingGeneticGenetic TranscriptionGrowthInfectionLaboratoriesLibrariesLightMalignant GliomaMalignant neoplasm of brainMapsMethodsModelingMolecularMotor NeuronsMusMutant Strains MiceMyelinNeural tubeOlig2 proteinOligodendrogliaOutcomePatientsPatternPattern FormationPhospho-Specific AntibodiesPhosphorylationPrecipitationPreclinical Drug EvaluationProcessProtein KinaseProteinsProtocols documentationReagentResearchRoleSerineShiveringSpinal CordSpinal cord injuryStem cellsSystemTestingTransgenic MiceWorkbasedaughter celldimerexpression vectorgene functionin vivokinase inhibitormimeticsmotor neuron developmentmouse modelmutantmyelinationnerve stem cellnoveloligodendrocyte lineageprogenitorprotein protein interactionpublic health relevancescaffoldself-renewalsingle moleculesmall hairpin RNAsmall moleculetooltranscription factorvector
项目摘要
DESCRIPTION (provided by applicant): The broad objective of the research proposed here is to define the molecular mechanisms that regulate oppositional functions of the bHLH transcription factor Olig2 on proliferation and differentiation of neural progenitor cells. In preliminary studies, we have identified a cluster of three serine residues ("Triple-S motif") in the amino terminus of Olig2 that are phosphorylated in cycling neural progenitors, but not in differentiated progeny. Mutational analysis indicates that phosphorylation of the Olig2 Triple-S motif is required for self-renewal of neural stem cells but is not required for Olig2-dependent specification of immature oligodendrocytes. The work proposed here builds upon these preliminary observations. We have five Specific Aims: Aim One is to identify the protein kinase(s) that phosphorylate Olig2 using small molecule kinase inhibitors and a kinome-wide ShRNAi library. Aim Two is to define Olig2 protein-protein interactions that are regulated by phosphorylation using "TAP- Tagged" wild type, phospho-null and phosphomimetic Olig2 proteins. Aim Three is to define the transcriptional functions of Olig2 phosphorylation to dictate the decision of neural progenitors to self renew or exit the cell cycle and differentiate. We will use ChIP/Seq protocols to identify direct genetic targets of phosphorylated Olig2. Aim Four is to determine a possible requirement for Olig2 Triple-S phosphorylation in embryonic patterning of spinal cord and in motor neuron development using a novel, bifunctional Olig2-tva-cre transgenic mouse neural tube explant system. Aim Five is to determine a possible requirement for Olig2 phosphorylation during oligodendrocyte maturation and CNS tumorgenesis in vivo. Orthotopic grafting studies will determine if Olig2 phosphorylation is essential for oligodendrocyte myelination, or alternatively, tumorgenesis in a mouse model of malignant glioma.
PUBLIC HEALTH RELEVANCE: The proposed work may shed light on molecular mechanisms that regulate neural progenitors in malignant gliomas, spinal cord injury and demyelinating diseases.
描述(由申请人提供):这里提出的研究的主要目的是确定bHLH转录因子Olig2对神经祖细胞增殖和分化的调控拮抗功能的分子机制。在初步研究中,我们在Olig2的氨基端发现了一个由三个丝氨酸残基组成的簇(“Triple-S基序”),在循环神经祖细胞中被磷酸化,但在分化的后代中没有磷酸化。突变分析表明,Olig2 Triple-S基序的磷酸化对于神经干细胞的自我更新是必需的,但对于未成熟少突胶质细胞的Olig2依赖性规范不是必需的。这里提出的工作建立在这些初步观察的基础上。我们有五个具体目标:目标一是利用小分子激酶抑制剂和全激酶ShRNAi文库鉴定磷酸化Olig2的蛋白激酶。目的二是定义由“TAP标记”野生型、无磷酸化和拟磷型Olig2蛋白磷酸化调控的Olig2蛋白-蛋白相互作用。目的三是明确Olig2磷酸化的转录功能,以决定神经祖细胞是自我更新还是退出细胞周期并分化。我们将使用ChIP/Seq协议来确定磷酸化Olig2的直接遗传靶点。目的四是利用一种新型的双功能Olig2-tva-cre转基因小鼠神经管移植系统,确定在脊髓胚胎模式和运动神经元发育中Olig2 Triple-S磷酸化的可能要求。目的五是确定体内少突胶质细胞成熟和中枢神经系统肿瘤发生过程中Olig2磷酸化的可能需求。原位移植研究将确定Olig2磷酸化是否对少突胶质细胞髓鞘形成或恶性胶质瘤小鼠模型中的肿瘤发生至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID H ROWITCH其他文献
DAVID H ROWITCH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID H ROWITCH', 18)}}的其他基金
Regulation of Cellular Pathwaysin Human Brain Development
人脑发育中细胞通路的调节
- 批准号:
8881350 - 财政年份:2014
- 资助金额:
$ 43.24万 - 项目类别:
Regulation of Cellular Pathwaysin Human Brain Development
人脑发育中细胞通路的调节
- 批准号:
9525442 - 财政年份:2014
- 资助金额:
$ 43.24万 - 项目类别:
Regulation of Cellular Pathwaysin Human Brain Development
人脑发育中细胞通路的调节
- 批准号:
8742981 - 财政年份:2014
- 资助金额:
$ 43.24万 - 项目类别:
Graduate Training Program in Neonatal-Perinatal Translational Research
新生儿-围产期转化研究研究生培训项目
- 批准号:
8658131 - 财政年份:2012
- 资助金额:
$ 43.24万 - 项目类别:
Graduate Training Program in Neonatal-Perinatal Translational Research
新生儿-围产期转化研究研究生培训项目
- 批准号:
8456051 - 财政年份:2012
- 资助金额:
$ 43.24万 - 项目类别:
Graduate Training Program in Neonatal-Perinatal Translational Research
新生儿-围产期转化研究研究生培训计划
- 批准号:
9038387 - 财政年份:2012
- 资助金额:
$ 43.24万 - 项目类别:
Graduate Training Program in Neonatal-Perinatal Translational Research
新生儿-围产期转化研究研究生培训项目
- 批准号:
8267939 - 财政年份:2012
- 资助金额:
$ 43.24万 - 项目类别:
相似海外基金
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
- 批准号:
10549640 - 财政年份:2023
- 资助金额:
$ 43.24万 - 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
- 批准号:
2750554 - 财政年份:2021
- 资助金额:
$ 43.24万 - 项目类别:
Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
- 批准号:
61319 - 财政年份:2020
- 资助金额:
$ 43.24万 - 项目类别:
Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10013588 - 财政年份:2020
- 资助金额:
$ 43.24万 - 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
- 批准号:
20K07009 - 财政年份:2020
- 资助金额:
$ 43.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
- 批准号:
10603473 - 财政年份:2020
- 资助金额:
$ 43.24万 - 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
- 批准号:
2342674 - 财政年份:2020
- 资助金额:
$ 43.24万 - 项目类别:
Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
- 批准号:
10117194 - 财政年份:2020
- 资助金额:
$ 43.24万 - 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10115604 - 财政年份:2020
- 资助金额:
$ 43.24万 - 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
- 批准号:
10294224 - 财政年份:2018
- 资助金额:
$ 43.24万 - 项目类别:














{{item.name}}会员




